Genenta Science SPA
NASDAQ:GNTA
Balance Sheet
Balance Sheet Decomposition
Genenta Science SPA
Current Assets | 21.3m |
Cash & Short-Term Investments | 18.8m |
Receivables | 2m |
Other Current Assets | 442.8k |
Non-Current Assets | 1.1m |
PP&E | 83k |
Other Non-Current Assets | 1m |
Current Liabilities | 1.7m |
Accounts Payable | 295k |
Accrued Liabilities | 1m |
Other Current Liabilities | 426k |
Non-Current Liabilities | 179.3k |
Other Non-Current Liabilities | 179.3k |
Balance Sheet
Genenta Science SPA
Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|
Assets | ||||||
Cash & Cash Equivalents |
20
|
15
|
37
|
30
|
4
|
|
Cash |
20
|
15
|
37
|
30
|
4
|
|
Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
15
|
|
Total Receivables |
0
|
1
|
1
|
2
|
2
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
|
Other Receivables |
0
|
0
|
1
|
2
|
2
|
|
Other Current Assets |
0
|
0
|
0
|
0
|
0
|
|
Total Current Assets |
21
|
17
|
39
|
32
|
21
|
|
PP&E Net |
0
|
0
|
0
|
0
|
0
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
0
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
|
Note Receivable |
1
|
1
|
1
|
2
|
1
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
21
N/A
|
18
-18%
|
40
+129%
|
33
-16%
|
22
-33%
|
|
Liabilities | ||||||
Accounts Payable |
0
|
1
|
0
|
1
|
0
|
|
Accrued Liabilities |
2
|
2
|
1
|
1
|
1
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
2
|
2
|
1
|
2
|
2
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
|
Total Liabilities |
3
N/A
|
2
-6%
|
1
-50%
|
2
+97%
|
2
-17%
|
|
Equity | ||||||
Common Stock |
0
|
0
|
66
|
67
|
67
|
|
Retained Earnings |
16
|
21
|
27
|
35
|
47
|
|
Additional Paid In Capital |
35
|
37
|
0
|
0
|
0
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
19
N/A
|
15
-20%
|
39
+157%
|
31
-20%
|
20
-34%
|
|
Total Liabilities & Equity |
21
N/A
|
18
-18%
|
40
+129%
|
33
-16%
|
22
-33%
|
|
Shares Outstanding | ||||||
Common Shares Outstanding |
18
|
18
|
18
|
18
|
18
|